Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,275 | 5 | 53.0% |
| Food and Beverage | $1,791 | 33 | 22.2% |
| Honoraria | $1,000 | 1 | 12.4% |
| Travel and Lodging | $912.20 | 6 | 11.3% |
| Education | $89.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $5,094 | 13 | $0 (2021) |
| G1 Therapeutics, Inc. | $1,324 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $711.37 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $687.31 | 8 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $65.74 | 3 | $0 (2024) |
| ATRICURE, INC. | $46.97 | 1 | $0 (2023) |
| EMD Serono, Inc. | $40.22 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $23.25 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $21.85 | 1 | $0 (2022) |
| RECORDATI_RARE_DISEASES_INC. | $21.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.44 | 3 | Janssen Biotech, Inc. ($34.29) |
| 2023 | $2,010 | 17 | G1 Therapeutics, Inc. ($1,324) |
| 2022 | $300.55 | 6 | Janssen Biotech, Inc. ($215.50) |
| 2021 | $5,679 | 20 | AbbVie Inc. ($5,094) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Oncology | ||||||
| 02/16/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 12/08/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 11/09/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Travel and Lodging | Cash or cash equivalent | $204.27 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $119.51 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $79.23 | General |
| Category: Oncology | ||||||
| 10/12/2023 | ATRICURE, INC. | ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device), ATRICLIP LAA EXCLUSION SYSTEM | Food and Beverage | In-kind items and services | $46.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Oncology | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: Oncology | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Oncology | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $115.37 | General |
| Category: Oncology | ||||||
| 04/13/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 03/08/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $109.44 | General |
| Category: Oncology | ||||||
| 03/08/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $109.44 | General |
| Category: Oncology | ||||||
| 01/19/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $119.81 | General |
| Category: Oncology | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), SCEMBLIX, TASIGNA | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Oncology | ||||||
| 06/16/2022 | Janssen Biotech, Inc. | BALVERSA (Drug) | Food and Beverage | In-kind items and services | $95.69 | General |
| Category: Oncology | ||||||
| 05/03/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 540 | 771 | $194,665 | $44,107 |
| 2022 | 15 | 599 | 954 | $268,855 | $61,089 |
| 2021 | 10 | 486 | 725 | $193,970 | $47,057 |
| 2020 | 20 | 1,054 | 1,680 | $162,544 | $30,687 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 334 | $123,040 | $27,163 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 80 | 98 | $48,608 | $11,581 | 23.8% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 15 | 18 | $9,414 | $2,192 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 50 | 67 | $1,340 | $562.80 | 42.0% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 15 | 16 | $2,288 | $560.48 | 24.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 34 | 39 | $2,340 | $521.04 | 22.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 33 | 42 | $2,688 | $434.70 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 41 | 52 | $1,872 | $395.72 | 21.1% |
| 83550 | Iron binding capacity | Office | 2023 | 34 | 39 | $1,365 | $334.23 | 24.5% |
| 83540 | Iron level | Office | 2023 | 34 | 39 | $1,053 | $247.26 | 23.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 11 | 15 | $465.00 | $88.80 | 19.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $192.00 | $26.40 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 525 | $193,200 | $44,112 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 91 | $45,136 | $10,856 | 24.1% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 19 | 19 | $9,937 | $2,258 | 22.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 14 | 18 | $5,256 | $977.41 | 18.6% |
| 99498 | Advance care planning, each additional 30 minutes | Office | 2022 | 14 | 18 | $4,590 | $843.85 | 18.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 46 | 58 | $2,088 | $444.90 | 21.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 34 | 39 | $2,496 | $406.20 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 62 | 79 | $1,580 | $234.21 | 14.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 12 | 14 | $1,064 | $207.82 | 19.5% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 14 | 15 | $900.00 | $201.73 | 22.4% |
| 82746 | Folic acid level, serum | Office | 2022 | 12 | 13 | $949.00 | $188.04 | 19.8% |
| 83550 | Iron binding capacity | Office | 2022 | 14 | 15 | $525.00 | $129.38 | 24.6% |
| 83540 | Iron level | Office | 2022 | 14 | 15 | $405.00 | $95.77 | 23.6% |
About Ashley Leon, FNP
Ashley Leon, FNP is a Family healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235687260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Leon, FNP has received a total of $8,067 in payments from pharmaceutical and medical device companies, with $77.44 received in 2024. These payments were reported across 46 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,275).
As a Medicare-enrolled provider, Leon has provided services to 2,679 Medicare beneficiaries, totaling 4,130 services with total Medicare billing of $182,939. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Austin, TX
- Active Since 09/20/2016
- Last Updated 02/28/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1235687260
Products in Payments
- VENCLEXTA (Drug) $5,094
- COSELA (Drug) $1,324
- ERLEADA (Drug) $390.57
- IMFINZI (Biological) $326.33
- LYNPARZA (Drug) $245.61
- TAGRISSO (Drug) $115.37
- DARZALEX (Biological) $114.55
- BALVERSA (Drug) $95.69
- IMBRUVICA (Drug) $89.00
- MYRISK (Device) $65.74
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) $46.97
- TEPMETKO (Drug) $24.33
- PROMACTA (Drug) $23.25
- OPDIVO (Biological) $21.85
- SYLVANT (Drug) $21.77
- BAVENCIO (Drug) $15.89
- PADCEV (Biological) $15.62
- TECVAYLI (Biological) $12.36
- DARZALEX (Drug) $9.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Austin
Monique Mulvany, N.p, N.P
Family — Payments: $68,796
Mrs. Chelsea Crilly, Fnp-C, FNP-C
Family — Payments: $29,209
Selina Gawriluk, Fnp-C, FNP-C
Family — Payments: $16,908
Michelle Escue, F.n.p, F.N.P
Family — Payments: $16,509
Kaycee Frederick, Np, NP
Family — Payments: $14,585
Megan Passe, Np-C, NP-C
Family — Payments: $14,260